author-image

Lee Yulin

ST Now Editor
Latest articles

US FDA approves Pfizer’s blood cancer therapy

The FDA approval is based on data from a mid-stage study that showed that 58 per cent of patients treated with Pfizer’s therapy had no signs of cancer or had seen a significant decrease in cancer cells in the body.